Corporate presentation would provide users with basic information about our company, so you can know us better.

1. www.cadilapharma.com

2. Serving mankind since 1951
We exist to care and bring
happiness and wellness to
millions of lives

3. The care continues…
We develop, manufacture and
market innovative and
affordable medical and health
solutions

4. Our legacy lives on…
Our parent company, Cadila
Laboratories established in
1951 was one of the earliest
pharmaceutical companies in
India

5. Indian company with a global presence
We are one of the largest
privately held pharmaceutical
companies in India with presence
in 5 Continents and over 100
Countries
(Global Sales - 2012 : US$ 2.0 Billion at US Price Parity)

6. Present across the entire Life Sciences
value chain
Research and development API Formulations Marketing and Distribution
20 ANDAs filed with USFDA
6 ANDAs approved
20 ANDAs in pipeline
30 USDMFs filed

7. Conforming to global standards
State-of-the-art
manufacturing
facilities
Dedicated world
class Research and
Development Center
Committed Contract
Research
Organisation
• cGMP compliant
• Approval from
WHO Geneva,
UK MHRA, TGA
Australia, MCC
South Africa,
ANVISA Brazil
and USFDA
• GCP, GLP compliant
state-of-the-art R&D
Centers for
API/F&D/Clinical
Research/ Biotechnology
• Development of non-
infringing technologies for
API and Bioequivalent
Formulations
• Domain Knowledge of
Clinical Research
(Phase-II to Phase-IV)

8. Manufacturing Facility, Dholka, Gujarat, India
API unit, Ankleshwar, Gujarat, India
Karnavati Engineering Ltd, Kadi, Gujarat, IndiaAgro Division, Hirapur, Gujarat, India
Manufacturing Facility, Addis Ababa, EthiopiaManufacturing Facility, Samba, Jammu, India
Corporate Campus, Bhat, Gujarat, India R&D Facility, Dholka, Gujarat, India
Casil Industries Ltd., Kadi, Gujarat, India
Our state-of-the-art facilities

9. To be a leading pharmaceutical company
in India and to become a significant
global player by providing high quality,
affordable and innovative solutions in
medicine and treatment.
Quality | Affordability | Innovations
Our vision

10. Quality | Affordability | Innovations
We will discover,
develop and
successfully market
pharmaceutical
products to prevent,
diagnose, alleviate
and cure diseases.
We shall provide total
customer satisfaction
and achieve leadership
in chosen markets,
products and services
across the globe,
through excellence in
technology, based on
world-class research
and development.
We are responsible to
the society. We shall be
a good corporate citizen
and will be driven by
high ethical standards in
our practices.
Our mission

11. Equipped with a dedicated
100,000 sft facility
Our 350 R&D scientists constantly
finding innovative solutions
• Dedicated Facilities
o Innovative Research
o Generics Research
• Formulation Development
o Novel Dosage Form Development
o Novel Drug Delivery Systems
• Biotechnology
o Vaccines, Diagnostics, Bio Therapeutics
• Chemical Research (API)
o Anti-Hypertensive, CNS,
Anti-Histaminic, Anti-Diabetic
o Anti-Ulcerants, Anti-Depressant,
Anti-Inflammatory
• CRO
o Clinical Pharmacology, Pharmaco-
Kinetics,
o Toxicity, Bio Availability and Bio
Equivalence Studies

12. Some of our first-in-the-world
innovations
Cadiflu-S
World’s first Virus Like Particle (VLP)
based vaccine for seasonal Influenza
Mycidac-C
An innovative research product for the
patients suffering from squamous Non
Small Cell Lung Cancer (NSCLC)
Risorine
A product that has revolutionised the
treatment for TB by reducing the dose of
Rifampicin and increasing the patient
compliance
Polycap
A pill that reduces the risk of CVD by
62% and stroke by 48%*
* The Lancet editorial – Sep. 2009
Rabeloc IV
Rabeprazole Sodium for
intravenous administration by rapid onset
of action, sustained and long term
lowering of gastric pH

13. Our focus areas for innovations
• Novel vaccines
• Better antibiotics
• Respiratory diseases
• Gastrointestinal diseases
• Cardiovascular ailments
• Diabetes
• Cancer
• Sepsis
• Regenerative medicine
Robust product pipeline to ensure continuous
growth in coming years

14. Our key alliances
Partnership for growth
with leading
international
companies in the
following areas:
• Vaccine development
• Biological therapeutics
and diagnostics
• Stem cell banking and
• Hospital management
Strategic alliances for developing
• Antibiotic Resistant Breakers and
• Novel solutions for COPD and
Asthma

15. Formulation Dosage
Sterile Forms Non-Sterile Forms
- Ampoules - Tablets-Coated / Uncoated
- Multi dose vials - Hard Gelatin Capsules
- Suspensions - Soft Gelatin Capsules
- Dry powders - Granules
- Eye & Ear drops - Dry Syrups
- Oral Liquids & Suspensions
API - Therapeutic Segments
- Cardiovascular - Erectile Dysfunction
- NSAIDs - Central Nervous System
- Antitubercular - Antiemetic
- Antiulcerant - Antiosteoporosis
- Antihistaminic - Antidiabetic
- Antiseptics - Antiasthmatic
Capabilities in handling variety of dosage forms in different therapies
Our range of offerings

16. Major Segments
Brand Building Initiatives - Therapeutic Areas
Cardiovascular Anti-infective
- Anti-hypertensives - Anti-bacterials
- Anti-anginals - Anti-virals
- Anti-arrhythmics - Anti-fungals
Gastrointestinal Nsaids
- Anti-ulcerants - Anti-histaminics/Cough
- Anti-spasmodics - Cortico-steroids
- Gastrointestinal anti-infectives - Vitamins / Haematinics
- Anti-emetics
- Anthelmintics
Neuropsychiatric Other Segments
- Anti-depressants - Anti-diabetics
- Anxiolytics - Lipid Lowering
- Oncology
• Gastroenterology
• Antimigraine
• Respiratory
• Cardiology
• Diabetology
• Antibiotics
Our chosen therapeutic segments

17. • Operations in more than 100 countries with 65+ distributors
• Structured operations, divided into 7 Regions
• More than 1200 product registrations available
(around 250 under process at MOH)
• Over 300 Multi-national, multi-cultural and multi-lingual sales force
Our global footprint

18. Our product range
Therapy Area # of Brands # of SKUs
Gastro Intestinal 61 109
Cardiac 57 107
Pain / Analgesics 56 70
Anti‐infectives 55 148
Respiratory 34 46
Vitamins / Minerals / Nutrients 31 48
Neuro / CNS 29 64
Derma 27 45
Oncology 23 41
Gynaec. 21 36
Anti‐Diabetic 15 30
Anti‐TB 11 17
Hormones 8 22
Urology 6 9
Blood Related 6 6
Anti‐Parasitic 6 12
Hepatoprotectives 4 5
Anti‐malarials 3 3
Vaccines 2 4
Grand Total 467 836

19. Our family
We are more than a
medicine company -
touching lives in
abundant ways

20. Our Asset
Our People

21. Life @ Cadila Pharma
Where
dedicated
people come to
work everyday
to make a
difference

22. Our Community
Our Responsibility

23. Our Kaka-Ba Hospital at Hansot
village in Gujarat, India has been
serving the poor by dedicated team
with modern infrastructure
Impacting lives positively

24. One of over 6,00,000
needy patients being
treated free of cost by
Kaka-Ba Hospital
Community care is our
way of life

25. Many underprivileged girls
are educated through our
Community Social
Responsibility initiatives

26. Few more snapshots
Conducted
5000+ Plastic
Surgeries for cleft
lip, cleft palate, post
burn contracture
and organ disability
Village
Development
to improve standard
of living for rural
community
500 Tribal Girls
trained and
employed as
Hospital
Attendants
Conducted
1000+ Health
Camps across
the State

27. Our Inspiration
Our Founder

28. “True celebration of research
lies as much in inventions as
in making the medicine
affordable to the last man in
the society”
Shri Indravadan A. Modi
Founder Chairman

29. Thank you